Category: Thoratec Corp.Syndicate content

Thoratec completes enrollment in HeartMate III study

December 1, 2014 by Val Kennedy

Thoratec completes enrollment in a European clinical trial for its HeartMate III left ventricular assist device.

Thoratec completes enrollment in HeartMate III study

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

LVAD slump? Thoratec dims outlook after Q3 earnings plunge

November 6, 2014 by Brad Perriello

Thoratec's 3rd-quarter earnings plunge nearly 85% as sales decline more than 16%, raising fears that the left ventricular-assist device market is in a slump that could persist into 2015.

LVAD slump? Thoratec dims outlook after Q3 earnings plunge

Thoratec (NSDQ:THOR) yesterday said its 3rd-quarter profits plunged some 85%, missing forecasts, and dimmed its outlook for the rest of the year.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Allergan CEO Pyott steps down from Edwards Lifesciences board | Personnel Moves

October 7, 2014 by Brad Perriello

Allergan CEO David Pyott steps down from the board at Edwards Lifesciences to devote more time to his chief executive duties.

Allergan CEO Pyott steps down from Edwards Lifesciences board | Personnel Moves

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Thoratec ousts Burbach, brings Grossman back

September 22, 2014 by Brad Perriello

Thoratec ousts CEO Gary Burbach and replaces him with predecessor Keith Grossman.

Thoratec's new study, $30M buyback can't stave off Wall Street exodus after dismal Q2

August 7, 2014 by Arezu Sarvestani

Thoratec's stock drops more than 26% in after-hours trading after the company lowers its full-year guidance on a dreary 2nd quarter.

New study, $30M buyback can't save Thoratec from Wall Street exodus after dismal Q2

Circulatory devices maker Thoratec (NSDQ:THOR) took a major hit yesterday as a bleak 2nd-quarter reports and a lowered outlook on the year sent its stock into a nosedive.

Covidien names Bill Burke as CFO to lead Medtronic merger | The week in medtech M&A

July 9, 2014 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Covidien taps integration chief to navigate Medtronic merger; Zimmer, Biomet appoint integration team; Thoratec inks $75M deal for Apica Cardiovascular; FTC wants more from Zimmer, Biomet on merger; Johnson & Johnson closes Ortho-Clinical Diagnostics sale

Covidien taps integration chief to navigate Medtronic merger

July 3, 2014 by Arezu Sarvestani

Covidien taps integration chief to navigate Medtronic merger
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp